- Home
- RWAY vs VALN Comparison
RWAY vs VALN Comparison
Compare RWAY & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWAY
- VALN
- Stock Information
- Founded
- RWAY 2015
- VALN 2012
- Country
- RWAY United States
- VALN France
- Employees
- RWAY N/A
- VALN N/A
- Industry
- RWAY
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RWAY
- VALN Health Care
- Exchange
- RWAY Nasdaq
- VALN Nasdaq
- Market Cap
- RWAY 390.5M
- VALN 378.3M
- IPO Year
- RWAY 2021
- VALN 2021
- Fundamental
- Price
- RWAY $10.31
- VALN $4.42
- Analyst Decision
- RWAY Buy
- VALN Strong Buy
- Analyst Count
- RWAY 9
- VALN 2
- Target Price
- RWAY $11.68
- VALN $18.50
- AVG Volume (30 Days)
- RWAY 340.5K
- VALN 25.3K
- Earning Date
- RWAY 11-12-2024
- VALN 11-07-2024
- Dividend Yield
- RWAY 3.88%
- VALN N/A
- EPS Growth
- RWAY N/A
- VALN N/A
- EPS
- RWAY 1.02
- VALN N/A
- Revenue
- RWAY $150,078,000.00
- VALN $176,817,979.00
- Revenue This Year
- RWAY N/A
- VALN $24.30
- Revenue Next Year
- RWAY N/A
- VALN $16.05
- P/E Ratio
- RWAY $10.07
- VALN N/A
- Revenue Growth
- RWAY N/A
- VALN N/A
- 52 Week Low
- RWAY $9.87
- VALN $4.27
- 52 Week High
- RWAY $13.74
- VALN $11.96
- Technical
- Relative Strength Index (RSI)
- RWAY 48.69
- VALN 25.94
- Support Level
- RWAY $9.92
- VALN $4.45
- Resistance Level
- RWAY $10.17
- VALN $4.73
- Average True Range (ATR)
- RWAY 0.22
- VALN 0.20
- MACD
- RWAY -0.01
- VALN -0.07
- Stochastic Oscillator
- RWAY 58.27
- VALN 9.03
About RWAY Runway Growth Finance Corp.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.